{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:19:40Z","timestamp":1791980380111,"version":"4.4.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T00:00:00Z","timestamp":1356048000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0052056","type":"journal-article","created":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T01:46:36Z","timestamp":1356140796000},"page":"e52056","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":131,"title":["Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer\u2019s Disease"],"prefix":"10.1371","volume":"7","author":[{"given":"Shreaya","family":"Chakroborty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clark","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan B.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Goussakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Wicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill C.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Conklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin G.","family":"Cameransi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace E.","family":"Stutzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,12,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer&apos;s disease: progress and problems on the road to therapeutics","volume":"297","author":"J Hardy","year":"2002","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1212\/WNL.0b013e318207b1b9","article-title":"Report of the task force on designing clinical trials in early (predementia) AD","volume":"76","author":"PS Aisen","year":"2011","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/1756285611404470","article-title":"Disease-modifying treatments for Alzheimer&apos;s disease","volume":"4","author":"D Galimberti","year":"2011","journal-title":"Ther Adv Neurol Disord"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer&apos;s disease: an appraisal for the development of therapeutics","volume":"10","author":"E Karran","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nm.2460","article-title":"Resolving controversies on the path to Alzheimer&apos;s therapeutics","volume":"17","author":"DJ Selkoe","year":"2011","journal-title":"Nat Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1212\/WNL.56.3.361","article-title":"Absence of cognitive impairment or decline in preclinical Alzheimer&apos;s disease","volume":"56","author":"WP Goldman","year":"2001","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.neurobiolaging.2009.04.002","article-title":"Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease","volume":"30","author":"JL Price","year":"2009","journal-title":"Neurobiol Aging"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1212\/WNL.55.3.370","article-title":"&quot;Preclinical&quot; AD revisited: Neuropathology of cognitively normal older adults","volume":"55","author":"FA Schmitt","year":"2000","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neurobiolaging.2003.09.001","article-title":"Synaptic slaughter in Alzheimer&apos;s disease","volume":"24","author":"PD Coleman","year":"2003","journal-title":"Neurobiol Aging"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JAD-2006-9S312","article-title":"Alzheimer&apos;s disease-related alterations in synaptic density: neocortex and hippocampus","volume":"9","author":"SW Scheff","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer&apos;s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"S Oddo","year":"2003","journal-title":"Neuron"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1523\/JNEUROSCI.0739-06.2006","article-title":"Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer&apos;s disease mice","volume":"26","author":"GE Stutzmann","year":"2006","journal-title":"J Neurosci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1523\/JNEUROSCI.2047-09.2009","article-title":"Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice","volume":"29","author":"S Chakroborty","year":"2009","journal-title":"J Neurosci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/chan.5.1.14124","article-title":"Generation of dendritic Ca2+ oscillations as a consequence of altered ryanodine receptor function in AD neurons","volume":"5","author":"I Goussakov","year":"2011","journal-title":"Channels (Austin)"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"12128","DOI":"10.1523\/JNEUROSCI.2474-10.2010","article-title":"NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer&apos;s disease mice","volume":"30","author":"I Goussakov","year":"2010","journal-title":"J Neurosci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.1523\/JNEUROSCI.0936-12.2012","article-title":"Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer&apos;s disease mice","volume":"32","author":"S Chakroborty","year":"2012","journal-title":"J Neurosci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"ra22","DOI":"10.1126\/scisignal.2000818","article-title":"Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimer&apos;s disease-linked presenilin mutants in human cells and mouse neurons","volume":"3","author":"KH Cheung","year":"2010","journal-title":"Sci Signal"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuron.2008.04.015","article-title":"Mechanism of Ca2+ disruption in Alzheimer&apos;s disease by presenilin regulation of InsP3 receptor channel gating","volume":"58","author":"KH Cheung","year":"2008","journal-title":"Neuron"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"13293","DOI":"10.1073\/pnas.1109297108","article-title":"Constitutive cAMP response element binding protein (CREB) activation by Alzheimer&apos;s disease presenilin-driven inositol trisphosphate receptor (InsP3R) Ca2+ signaling","volume":"108","author":"M Muller","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"8566","DOI":"10.1523\/JNEUROSCI.1554-10.2010","article-title":"Role of presenilins in neuronal calcium homeostasis","volume":"30","author":"H Zhang","year":"2010","journal-title":"J Neurosci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0306-4522(99)00042-1","article-title":"Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer&apos;s disease neurofibrillary and beta-amyloid pathologies","volume":"92","author":"M Kelliher","year":"1999","journal-title":"Neuroscience"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1471-4159.2009.06487.x","article-title":"Up-regulation of the type 3 ryanodine receptor is neuroprotective in the TgCRND8 mouse model of Alzheimer&apos;s disease","volume":"112","author":"C Supnet","year":"2010","journal-title":"J Neurochem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1196\/annals.1379.025","article-title":"Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer&apos;s mouse models","volume":"1097","author":"GE Stutzmann","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.neulet.2012.04.008","article-title":"Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice","volume":"516","author":"J Peng","year":"2012","journal-title":"Neurosci Lett"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1523\/JNEUROSCI.0875-12.2012","article-title":"Ryanodine Receptor Blockade Reduces Amyloid-beta Load and Memory Impairments in Tg2576 Mouse Model of Alzheimer Disease","volume":"32","author":"B Oules","year":"2012","journal-title":"J Neurosci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainres.2004.05.029","article-title":"Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes","volume":"1017","author":"DR Howlett","year":"2004","journal-title":"Brain Res"},{"key":"ref27","first-page":"21","article-title":"Neuroprotection for nerve agent-induced brain damage by blocking delayed calcium overload: a review","volume":"3","author":"LE Filbert M","year":"2005","journal-title":"J Med CBR Def"},{"key":"ref28","first-page":"67","article-title":"Abeta deposition and related pathology in an APP\u00d7PS1 transgenic mouse model of Alzheimer\u2019s disease","volume":"23","author":"DR Howlett","year":"2008","journal-title":"Histol Histopathol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1152\/physiol.00028.2004","article-title":"Dynamic multiphoton imaging: a live view from cells to systems","volume":"20","author":"GE Stutzmann","year":"2005","journal-title":"Physiology (Bethesda)"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/1073858407299730","article-title":"The pathogenesis of Alzheimers disease is it a lifelong &quot;calciumopathy&quot;?","volume":"13","author":"GE Stutzmann","year":"2007","journal-title":"Neuroscientist"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1523\/JNEUROSCI.4386-03.2004","article-title":"Dysregulated IP3 signaling in cortical neurons of knock-in mice expressing an Alzheimer&apos;s-linked mutation in presenilin1 results in exaggerated Ca2+ signals and altered membrane excitability","volume":"24","author":"GE Stutzmann","year":"2004","journal-title":"J Neurosci"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Bruno AM, Huang JY, Bennett DA, Marr RA, Hastings ML, <etal>et al<\/etal>.. (2012) Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer&apos;s disease. Neurobiol Aging 33: 1001 e1001\u20131006.","DOI":"10.1016\/j.neurobiolaging.2011.03.011"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"12463","DOI":"10.1074\/jbc.R109.080895","article-title":"Calcium signaling and amyloid toxicity in Alzheimer disease","volume":"285","author":"A Demuro","year":"2010","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ceca.2011.11.008","article-title":"Amyloid beta peptide 1\u201342 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures","volume":"51","author":"IL Ferreira","year":"2012","journal-title":"Cell Calcium"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e18250","DOI":"10.1371\/journal.pone.0018250","article-title":"Calcium ions promote formation of amyloid beta-peptide (1\u201340) oligomers causally implicated in neuronal toxicity of Alzheimer&apos;s disease","volume":"6","author":"A Itkin","year":"2011","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"304583","DOI":"10.4061\/2011\/304583","article-title":"Membrane Incorporation, Channel Formation, and Disruption of Calcium Homeostasis by Alzheimer&apos;s beta-Amyloid Protein","volume":"2011","author":"M Kawahara","year":"2011","journal-title":"Int J Alzheimers Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1046\/j.1471-4159.2003.02227.x","article-title":"Intraneuronal amyloid-beta1\u201342 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death","volume":"88","author":"N Pierrot","year":"2004","journal-title":"J Neurochem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1021\/bi00181a016","article-title":"Calcium ionophore increases amyloid beta peptide production by cultured cells","volume":"33","author":"HW Querfurth","year":"1994","journal-title":"Biochemistry"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF03033284","article-title":"Tau in neurodegenerative diseases: tau phosphorylation and assembly","volume":"6","author":"J Avila","year":"2004","journal-title":"Neurotox Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1083\/jcb.201104133","article-title":"Single-channel Ca(2+) imaging implicates Abeta1\u201342 amyloid pores in Alzheimer&apos;s disease pathology","volume":"195","author":"A Demuro","year":"2011","journal-title":"J Cell Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"39907","DOI":"10.1074\/jbc.M606015200","article-title":"Calcium-mediated transient phosphorylation of tau and amyloid precursor protein followed by intraneuronal amyloid-beta accumulation","volume":"281","author":"N Pierrot","year":"2006","journal-title":"J Biol Chem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12028-008-9133-4","article-title":"Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unit","volume":"10","author":"S Muehlschlegel","year":"2009","journal-title":"Neurocrit Care"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrd3288","article-title":"Alzheimer&apos;s failure raises questions about disease-modifying strategies","volume":"9","author":"A Extance","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","volume":"61","author":"JM Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1471-4159.2011.07213.x","article-title":"Targets for AD treatment: conflicting messages from gamma-secretase inhibitors","volume":"117","author":"K Sambamurti","year":"2011","journal-title":"J Neurochem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"S Gilman","year":"2005","journal-title":"Neurology"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Holtzman DM, Goate A, Kelly J, Sperling R (2011) Mapping the road forward in Alzheimer&apos;s disease. Sci Transl Med 3: 114 ps148.","DOI":"10.1126\/scitranslmed.3003529"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"13810","DOI":"10.1074\/jbc.M006104200","article-title":"Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity","volume":"276","author":"F Zhao","year":"2001","journal-title":"J Biol Chem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"38440","DOI":"10.1074\/jbc.M606736200","article-title":"Amyloid-beta-(1\u201342) increases ryanodine receptor-3 expression and function in neurons of TgCRND8 mice","volume":"281","author":"C Supnet","year":"2006","journal-title":"J Biol Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0052056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T14:56:34Z","timestamp":1745938594000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0052056"}},"subtitle":[],"editor":[{"given":"Sergio T.","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,21]]},"references-count":49,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0052056","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,21]]}}}